Whitepaper: Application of CRISPR/Cas to the generation of genetically engineered mice
Posted: 7 January 2019 | Taconic Biosciences | No comments yet
Learn how the continued development of CRISPR gene editing technologies opens fresh possibilities for in vivo model design.
CRISPR/Cas-based gene editing technologies continue to expand the capabilities of bioscience and drug discovery researchers. Existing processes have matured, while whole new applications — such as large, exogenous insertions — open exciting possibilities for efficiently modelling human disease.
Download this updated white paper to find out how CRISPR/Cas technologies can streamline and accelerate your genetic engineering projects, while costing significantly less than pre-CRISPR gene editing techniques.
The rest of this whitepaper is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related content from this organisation
Related topics
CRISPR, Drug Discovery, Drug Discovery Processes, Genomics, In Vivo, Informatics, Screening, Sequencing, Stem Cells, Translational Science
Related organisations
Taconic Biosciences
